ReviewJournal of the National Comprehensive Cancer Network : JNCCN2013
The phosphoinositide-3-kinase-Akt-mTOR pathway as a therapeutic target in breast cancer.
Josh Lauring et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
58 papers cite it
this paperpooled ittrialcites it